Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete, … see more Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete, 613743 (46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency syndrome) (CYP11A1 gene) (Sequence Analysis-All Coding Exons) (Prenatal)  see less
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000576705.1
INHERITED DISEASEDYSMORPHOLOGYENDOCRINOLOGY ... View more
Registered in GTR: 2020-05-19
Last annual review date for the lab: 2022-05-14 Past due LinkOut
At a Glance
Diagnosis
Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency
Genes (1): Help
CYP11A1 (15q24.1)
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete, …
Not provided
Not provided
Ordering Information
Offered by: Help
Test Order Code: Help
717
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 1
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis
Target population: Help
Adrenal insufficiency, congenital, with 46,XY sex reversal, partial or complete, 613743 (diagnosis/ clinical suspition/ etiology investigation/ classification)
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Sensitivity of this method was reported as 99,9996%. This value may change in some special DNA regions
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.